Breast cancer in BRCA mutations carriers: is it time for a "lifestyle" primary prevention?

Epidemiol Prev. 2018 Sep-Dec;42(5-6):369-371. doi: 10.19191/EP18.5-6.P369.107.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • BRCA1 Protein / physiology
  • BRCA2 Protein / physiology
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Clinical Trials as Topic
  • Comorbidity
  • Contraceptives, Oral, Hormonal / pharmacology
  • Contraceptives, Oral, Hormonal / therapeutic use
  • Diet
  • Down-Regulation
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Counseling
  • Humans
  • Insulin Resistance*
  • Insulin-Like Growth Factor I / physiology
  • Life Style*
  • Metabolic Syndrome / diet therapy
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / physiopathology
  • Milk / adverse effects
  • Mutation
  • Obesity / diet therapy
  • Obesity / epidemiology
  • Obesity / physiopathology
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / prevention & control
  • Primary Prevention / methods*
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / physiology
  • Weight Gain

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • Contraceptives, Oral, Hormonal
  • IGF1 protein, human
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1